Substance | Condition | Seq | Src | PMID | Dtl | Title |
Cranberry | Acute Myeloid Leukemia | 1 | PM | 31698457 | 📋 | Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells |
Cranberry | Acute Promyelocytic Leukemia | 1 | PM | 32143616 | 📋 | Cranberry extract initiates intrinsic apoptosis in HL-60 cells by increasing BAD activity through inhibition of AKT phosphorylation |
Cranberry | Bladder Cancer | 1 | PM | 27711848 | 📋 | Metabolism and growth inhibitory activity of cranberry derived flavonoids in bladder cancer cells |
Cranberry | Breast Cancer | 1 | PM | 16377076 | 📋 | Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells |
Cranberry | Cancer | 1 | PM | 27548236 | 📋 | Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents |
Cranberry | Cancer | 2 | PM | 15113149 | 📋 | Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines |
Cranberry | Colon Cancer | 3 | PM | 32390426 | 📋 | Bioactive Components of Polyphenol-Rich and Non-Polyphenol-Rich Cranberry Fruit Extracts and Their Chemopreventive Effects on Colitis-Associated Colon Cancer |
Cranberry | Colon Cancer | 2 | PM | 31750473 | 📋 | Non-extractable polyphenols from cranberries: potential anti-inflammation and anti-colon-cancer agents |
Cranberry | Colon Cancer | 1 | PM | 30353672 | 📋 | Chemopreventive Effects of Whole Cranberry (Vaccinium macrocarpon) on Colitis-Associated Colon Tumorigenesis |
Cranberry | Colorectal Cancer | 2 | PM | 32185816 | 📋 | The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions |
Cranberry | Colorectal Cancer | 1 | PM | 29228651 | 📋 | Dietary feeding of freeze-dried whole cranberry inhibits intestinal tumor development in Apcmin/+ mice |
Cranberry | Esophageal Cancer | 4 | PM | 38139823 | 📋 | Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model |
Cranberry | Esophageal Cancer | 3 | PM | 35267943 | 📋 | Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights |
Cranberry | Esophageal Cancer | 1 | PM | 26378019 | 📋 | Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation |
Cranberry | Esophageal Cancer | 2 | PM | 18211022 | 📋 | Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells |
Cranberry | Glioblastoma | 1 | PM | 34230129 | 📋 | Cranberry Extract Is a Potent Radiosensitizer for Glioblastoma |
Cranberry | Lung Cancer | 1 | PM | 37351982 | 📋 | Say 'No' to Cancer and 'Yes' to Cranberry: The Role of Cranberry Extract in Inhibition of Growth of Lung Adenocarcinoma Cells |
Cranberry | Oral Cancer | 2 | PM | 37375955 | 📋 | The Protective Role of Cranberries and Blueberries in Oral Cancer |
Cranberry | Oral Cancer | 1 | PM | 33456234 | 📋 | Anticancer and antiproliferative efficacy of a standardized extract of Vaccinium macrocarpon on the highly differentiating oral cancer KB cell line athwart the cytotoxicity evaluation of the same on the normal fibroblast L929 cell line |
Cranberry | Ovarian Cancer | 1 | PM | 25776829 | 📋 | The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells |
Cranberry | Ovarian Cancer | 3 | PM | 21922132 | 📋 | Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells |
Cranberry | Ovarian Cancer | 2 | PM | 19172579 | 📋 | Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin |
Cranberry | Prostate Cancer | 1 | PM | 27833172 | 📋 | Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings |